Lidocaine Spray vs Viscous Lidocaine Solution Plus Lidocaine Spray in Patients Undergoing Non-Sedated EGD

• Status: Enrolling by invitation
• Trial end date: 2024-10-30
• Target enrollment: 0
• Participant gender: All

Summary

This study aimed to compare the efficacy of lidocaine spray (S) alone versus lidocaine spray combined with lidocaine viscous solution (S+V) in facilitating pharyngeal observation during Non-sedating upper gastrointestinal endoscopy (UGE).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sawanpracharak hospital
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Patients scheduled for upper gastrointestinal endoscopy:

• Patients who are robust, without chronic illnesses, or with controlled chronic conditions that do not adversely affect the function of any organ (American Society of Anesthesiologists (ASA) physical status classification I-II).

Exclusion Criteria:

• Has a history of receiving painkillers or sleeping pills within 24 hours before the endoscopy.

• Has a history of post-endoscopy nausea and vomiting.

• Patients who have undergone upper gastrointestinal endoscopy previously.

• Has chronic conditions such as epilepsy, vertigo, or mental health disorders.

• Has a history of allergy to anesthesia used in the study.

• Pregnant or currently breastfeeding.

• Refuses to participate in the study.